GENERAL ATLANTIC, L.P. Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$2.9T
Holdings
13
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (13 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DLODLOCAL | 46,656,695 | $659.7B | 22.97% | |
| 2 | CHYMCHIME | 21,259,683 | $535.1B | 18.63% | |
| 3 | XPXP, INC | 22,699,133 | $371.6B | 12.93% | |
| 4 | ALKTALKAMI | 11,991,480 | $276.6B | 9.63% | |
| 5 | ALHCALIGNMENT HEALTHCARE | 13,167,733 | $260.1B | 9.05% | |
| 6 | RVMDREVOLUTION MEDICINES | 2,812,928 | $224.0B | 7.80% | |
| 7 | PHVSPHARVARIS | 8,031,252 | $222.9B | 7.76% | |
| 8 | CNTACENTESSA PHARMACEUTICALS | 6,117,715 | $153.0B | 5.33% | |
| 9 | NRIXNURIX THERAPEUTICS | 4,897,159 | $92.9B | 3.23% | |
| 10 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $47.2B | 1.64% | |
| 11 | RSKDRISKIFIED | 5,324,998 | $26.5B | 0.92% | |
| 12 | GROVGROVE COLLABORATIVE | 2,474,859 | $2.7B | 0.09% | |
| 13 | BULLWEBULL | 50,816 | $394.0M | 0.01% |